KODEX – EPD- Patient Specific Optimized Therapy (PSOT)

Build status - In Progress

Recruiting

18 years - 99 years

All

Phase N/A

25 participants needed

1 Location

Brief description of study

The purpose of this research study is to collect data from arrhythmia patients undergoing catheter-based electrophysiological (EP) intervention (ablation procedures), in which the FDA approved medical device KODEX-EPD system will be used, in order to develop a patient specific optimized therapy.

Arrhythmia patients indicated for EP procedures will be recruited from Penn Medicine outpatient and inpatient clinics.

Detailed description of study

If you agree to join the study, you will be asked to complete the following three follow up visits, at 12 months post procedure, 24 months post procedure and 36 months post procedure.

These visit can be in-person clinic visit or by telephone.

Your participation will last about 3 years.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Arrhythmia,indicated for electrophysiological procedures
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 834416

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.